Market Signal Briefing

These Marijuana Stocks Are The Winner Investors Speak On

2 minute read

Here Are Marijuana Stocks To Watch In This Momentum Swing
The outlier to seeing better trading for marijuana stocks falls under several categories. First, reform measures and state-level regulatory and tax issues should be addressed in the interest in small and more mom-and-pop cannabis companies. Yet, the big boys of the game are looking to dominate each market through MSOs and ancillary services. In fact, the ancillary market does better at times than selling actual cannabis flower.

Companies like Grow Generation, which specialize in selling cultivation equipment. But what is pushing the needle for all these companies is changing laws and working to establish a stronger foundation for a better foot forward. Investors are thinking the same way, as they see most stocks as long-term investments. The success, growth, and power of all legal markets show more proof of concept.

There is a worldwide community of cannabis users who want the best at affordable prices. So companies are building and working through this legal landscape to meet these consumer demands. If companies can continue to show profits are being made as a business, it offers more hope that things will ultimately resonate into better trading. For now, many are starting, taking what profits can be made in recent momentum shifts for the cannabis stock market. Below are several marijuana stocks to watch this month.

Top Marijuana Stocks For Investors Today

FLUENT Corp. (OTC:CNTMF)
Ayr Wellness Inc. (OTC:AYRWF)
Verano Holdings Corp. (OTC:VRNOF)

FLUENT Corp.
FLUENT Corp., through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. 

In the most recent news, the company announced a private placement financing. The Offering is being completed solely with the Company’s new Interim Chief Executive Officer, David Vautrin, in connection with his employment agreement with the Company.

Ayr Wellness Inc.
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. 

Back on September 12th, the company announced it had filed its unaudited interim condensed consolidated financial statements for Q1 2025.

[Read More] 3 Marijuana Stocks To Buy In 2025 While The Sector Rebuilds

Verano Holdings Corp.
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. At the start of October, the company announced it had secured a $75,000,000 revolving credit facility.

[Read More] 3 Marijuana Penny Stocks Poised for Growth in the Expanding U.S. Cannabis Market

Words From The Company
“Closing the $75 million revolving credit facility demonstrates our focus on fortifying the balance sheet, accessing lower cost debt, and leveraging our owned real estate to strengthen our foundation and position Verano to take advantage of future opportunities,” said George Archos, Verano founder and Chief Executive Officer.”

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | [email protected]

October 03, 2025 09:25 ET

 | Source:

Merit Medical Systems, Inc.

SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.

Contacts: PR/Media Inquiries:Investor Inquiries:Sarah ComstockMike Piccinino, CFA, IRCMerit MedicalICR Healthcare+1-801-432-2864+1-443-213-0509sarah.comstock@[email protected]

OpenAI now has two of the top three free apps in Apple's App Store, and its new video generation app Sora has snagged the coveted No. 1 spot.

The artificial intelligence startup launched Sora on Tuesday, and it allows users to generate short-form AI videos, remix videos created by other users and post them to a shared feed. Sora is only available on iOS devices and is invite-based, which means users need a code to access it.

Despite these restrictions, Sora has secured the top spot in the App Store, ahead of Google's Gemini and OpenAI's generative chatbot ChatGPT.

"It's been epic to see what the collective creativity of humanity is capable of so far," Bill Peebles, head of Sora at OpenAI, wrote in a post on X on Friday. "Team is iterating fast and listening to feedback."

Read more CNBC tech newsOpenAI wraps $6.6 billion share sale at $500 billion valuationTokenization of real world assets is an unstoppable 'freight train' coming to major markets: Robinhood CEOTaiwan rejects U.S. proposal for '50-50′ chip production, says trade talks focused on tariffsNASA employees on Artemis missions with SpaceX, Blue Origin to work through shutdownSora is powered by OpenAI's latest video and audio generation model called Sora 2. OpenAI said the model is capable of creating scenes and sounds with "a high degree of realism," according to a blog post. The startup's first video and audio generation model, Sora, was announced in February 2024.

OpenAI said it has taken steps to address potential safety concerns around the Sora app, including giving users explicit control over how their likeness is used on the platform. But some of the initial videos posted to the app, including one that depicts OpenAI CEO Sam Altman shoplifting, have sparked debates about its utility, potential for harm and legality.

"It is easy to imagine the degenerate case of AI video generation that ends up with us all being sucked into an RL-optimized slop feed," Altman wrote in a post on X on Tuesday. "The team has put great care and thought into trying to figure out how to make a delightful product that doesn't fall into that trap, and has come up with a number of promising ideas."

watch now

The near-term outlook for the Zacks Industrial Services industry appears encouraging, supported by rising e-commerce activity and a recent uptick in the production index. Industry participants are focused on strategic pricing, cost-reduction initiatives and enhancing productivity and efficiency to boost margins.

Companies such as Fastenal (FAST - Free Report) , MSC Industrial Direct Co., Inc. (MSM - Free Report) and ScanSource (SCSC - Free Report) are well-positioned to benefit from these trends. They are actively cutting costs, improving operational efficiency and investing in automation and digitization, moves that are expected to drive sustainable growth and strengthen their market position in the coming quarters.

Industry Description
The Zacks Industrial Services industry comprises companies that provide industrial equipment products and MRO (maintenance, repair and operations) services. It includes routine maintenance, emergency maintenance and spare part inventory control, which keep a facility and its equipment in good operating condition. Industry participants serve a wide array of customers, ranging from commercial, government and healthcare to manufacturing. The industry's products (power tools, hand tools, cutting fluids, lubricants, personal protective equipment and consumables) are utilized in production and plant maintenance but are not directly related to customers’ core products or services. These companies reduce MRO supply-chain costs and improve customers' plant floor productivity by offering inventory management and process and procurement solutions.

Trends Shaping the Future of the Industrial Services Industry
E-Commerce to be a Growth Driver: MRO demand is significantly impacted by the evolution of e-commerce. Customer demand for highly tailored solutions, with real-time access to information and rapid delivery of products, is rising. Customers want to execute their business activities in the most efficient way possible, which often means online. E-commerce is expected to surge due to rising Internet penetration, widespread smartphone adoption and the convenience of online shopping. Additionally, advancements in digital payments, logistics and personalization are making the online shopping experience faster, safer and more customer-centric. To capitalize on this trend, industrial service companies are heavily investing in improving their digital capabilities and increasing their e-commerce share.

Production Index Enters Expansion Territory:  The manufacturing sector contributes around 70% to the industry's revenues. The Institute for Supply Management’s manufacturing index has been in contraction for the past seven months and registered 49.1% in September. It, however, marked a slight increase from the 48.7% in August. The Production Index entered expansion territory again (after contracting in August), registering 51%. Notably, the index had been above 50% (indicating expansion) in June and July. This looks promising for the industry. 

Pricing Actions to Combat High Costs: The industry has been experiencing significant inflation levels, including higher prices for labor, freight and fuel. The companies are witnessing labor shortages for some positions and incurring steep labor costs to meet demand. The imposition of tariffs and retaliatory tariffs will also heighten costs for the industry.  Industry players are focusing on pricing actions, cost-cutting measures, efforts to improve productivity and efficiency and the diversification of the supplier base to mitigate some of these headwinds.

Zacks Industry Rank Indicates Bright Prospects
The group’s Zacks Industry Rank, basically the average of the Zacks Rank of all the member stocks, indicates encouraging prospects in the near term. The Zacks Industrial Services Industry, a 19-stock group within the broader Zacks Industrial Products sector, currently carries a Zacks Industry Rank #77, which places it in the top 31% of 245 Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.

Before we present a few Industrial services stocks that investors can add to their portfolio, it is worth taking a look at the industry’s stock-market performance and its valuation picture.

Industry Vs S&P 500 & Sector
The Industrial Services industry has outperformed its sector but lagged the Zacks S&P 500 composite over the past year. Over this period, the industry has grown 6.5% compared with the sector’s rise of 5.1%. The Zacks S&P 500 composite has moved up 18.9%.

One-Year Price PerformanceIndustry's Current Valuation
On the basis of the forward 12-month EV/EBITDA ratio, a commonly used multiple for valuing Industrial Services companies, we see that the industry is currently trading at 36.39X compared with the S&P 500’s 18.64X and the Industrial Products sector’s forward 12-month EV/EBITDA of 19.85X. This is shown in the charts below.

Enterprise Value/EBITDA (EV/EBITDA) TTM Ratio

Enterprise Value/EBITDA (EV/EBITDA) TTM Ratio

Over the last five years, the industry traded as high as 40.32X and as low as 24.34X, the median being 33.79X.

3 Industrial Services Stocks to Buy
ScanSource: The company recently announced a new resale relationship with Zoom Communications, Inc., which provides ScanSource partners with greater flexibility to deliver cloud-based collaboration technology solutions. Despite cautious technology spending weighing on revenues, the company’s shifting business mix, operational execution and cost-saving efforts have been driving stronger margins and cash flow. Debt reduction, shareholder returns and strategic acquisitions remain key priorities. Acquisitions of Resourcive and Advantix have been accretive to fiscal 2025 earnings. Resourcive delivers strategic IT sourcing solutions to the mid-market and enterprise businesses, while Advantix specializes in wireless enablement solutions. Looking ahead, the company maintains a strong acquisition pipeline and intends to pursue strategic investments in fiscal 2026 to accelerate growth and drive margin expansion. SCSC shares have appreciated 44.8% in the past six months.

The Zacks Consensus Estimate for Greenville, SC-based ScanSource’s fiscal 2025 earnings has moved north by 7.9% in the past 90 days. The consensus mark indicates year-over-year growth of 11%. SCSC has a long-term estimated earnings growth rate of 15% and currently sports a Zacks Rank #1 (Strong Buy).

You can see the complete list of today’s Zacks #1 Rank stocks here.

Price & Consensus: SCSC
 

Fastenal:  The company is benefiting from steady daily sales growth, improved customer contract signings and leverage from its focus on eBusiness and Digital Footprint. In the second quarter of 2025, daily eBusiness sales rose 13.5%. Sales through Digital Footprint were 61% of total sales compared with 59.4% in the year-ago quarter. The company aims to lift its share from Digital Footprint further to 63-64% in 2025. Fastenal is also making concerted efforts to control costs and offset cost inflation, particularly in container and transportation costs. The strategies for the same include automating warehouses, increasing delivery efficiency through its trucking network and selling more private-label products with higher margins. This will aid the company to improve its efficiency and also boost margins. The company’s shares have gained 29.5% in the past six months.

The Zacks Consensus Estimate for the Winona, MN-based company’s fiscal 2025 earnings has moved up 1.8% in the past 90 days. The consensus mark indicates year-over-year growth of 11%. FAST has a long-term estimated earnings growth rate of 9.9% and currently carries a Zacks Rank #2 (Buy).

Price & Consensus: FAST

MSC Industrial: The company recently indicated that, supported by stronger-than-expected average daily sales in June and July, it expects fiscal fourth-quarter results (ended Aug. 31, 2025) to land in the upper half of its guided range. MSM had projected average daily sales growth between a decline of 0.5% and an increase of 1.5%, with an adjusted operating margin of 8.5–9%. In the prior fiscal third quarter, management highlighted positive trends, including sequential improvement among core customers, momentum in high-touch solutions and a growing productivity pipeline. Looking ahead, the company remains committed to its long-term goals of delivering growth at least 400 basis points above the IP Index and expanding operating margins to the mid-teens. To support these objectives, MSM continues to pursue strategic acquisitions aimed at strengthening its offerings and expanding into new and existing markets. MSC Industrial’s shares have gained 29.2% in the past six months.

The Zacks Consensus Estimate for Melville, NY-based MSM’s 2025 earnings has moved up 0.5% in the past 90 days. The company has a trailing four-quarter earnings surprise of 5.98% on average. It currently carries a Zacks Rank of 2.

Price & Consensus: MSM

Key Takeaways ANGO's Q1 loss per share of 10 cents beat estimates and improved from last year.ANGO's Q1 revenues rose 12.2% to $75.7M, led by 26.1% growth in the Med Tech segment.ANGO raised FY26 sales outlook to $308-$313M on strong Med Tech performance.
AngioDynamics, Inc. (ANGO - Free Report) reported a pro-forma adjusted loss per share of 10 cents for first-quarter fiscal 2026, marking an improvement from the year-ago quarter’s adjusted loss of 11 cents. The Zacks Consensus Estimate for the metric was pegged at a loss of 14 cents.

Pro-forma basis excludes the divested Dialysis and BioSentry businesses, the divested PICC and Midline product portfolios and the discontinued Radiofrequency and Syntrax products.

On a pro-forma basis, the fiscal first-quarter GAAP loss per share was 26 cents, reflecting an improvement from the year-ago quarter’s loss of 32 cents.

ANGO’s Revenue DetailsPro-forma revenues in the fiscal first quarter totaled $75.7 million, up 12.2% year over year on a reported basis. The top line outpaced the Zacks Consensus Estimate by 4.8%.

The company continued to see strong contributions from its Med Tech (which includes the Auryon peripheral atherectomy platform, the thrombus management platform and the NanoKnife irreversible electroporation platform) and Med Device businesses during the quarter.

Shares of this company gained nearly 6% in yesterday’s trading. Share of ANGO have gained 27.5% so far this year against the industry's decline of 8.7%. The S&P 500 Index was up 15.2% in the same time period

Image Source: Zacks Investment Research

AngioDynamics’ Geographical AnalysisIn the quarter under review, U.S. net revenues totaled $66.5 million, up 11.7% year over year. Our estimate for the metric was $62.3 million.

Pro-forma International revenues totaled $9.3 million, up 15.6% from the year-ago quarter’s level on a reported basis. Our projection for the metric was $10.2 million.

ANGO’s Segmental AnalysisAngioDynamics derives revenues from two businesses — Med Tech and Med Device.

The Med Tech business’ pro-forma net sales in the fiscal first quarter were $35.3 million, reflecting an uptick of 26.1% year over year. Our projection for the metric was $32.7 million.

The rise was primarily driven by increased net sales of Auryon, which amounted to $16.5 million (up 20.1% year over year), and Mechanical Thrombectomy revenues (including AngioVac and AlphaVac) of $11.3 million (up 41.2% year over year). AngioVac revenues totaled $8 million (up 37.1% year over year) and AlphaVac revenues amounted to $3.3 million (up 52.3% year over year). Total NanoKnife revenues were $6.4 million, up 26.7% year over year.

Pro-forma Med Device revenues totaled $40.5 million, up 2.3% from the year-ago period’s level. This figure compares to our projection of $39.9 million.

AngioDynamics’ Margin AnalysisIn the quarter under review, AngioDynamics’ pro forma gross profit rose 14% to $41.9 million. The pro forma gross margin expanded 90 basis points to 55.3%. We had projected a pro forma gross margin of 54.2% for the quarter.

Sales and marketing expenses on a pro forma basis increased 9.9% year over year to $28.1 million. Research and development expenses on a pro forma basis increased 2.1% to $6.4 million, while general and administrative expenses rose 14.4% to $12.6 million. On a pro forma basis, adjusted operating expenses of $47.102 million increased 9.9% year over year.

The adjusted operating loss on a pro forma basis totaled $5.2 million compared with the prior-year quarter’s loss of $6.1 million.

ANGO’s Cash PositionAngioDynamics exited the first quarter of fiscal 2026 with cash and cash equivalents of $38.8 million compared with $55.9 million at the end of fiscal 2025.

The company ended the quarter with no debt on its balance sheet.

Cumulative net cash used in operating activities was $15.9 million compared with $18.3 million a year ago.

AngioDynamics’ FY26 GuidanceAngioDynamics has updated its guidance for fiscal 2026.

The company expects net sales to be in the range of $308-$313 million, up from the previous guidance of $305-$310 million. The Zacks Consensus Estimate is currently pegged at $306.3 million.

AngioDynamics now expects its Med Tech revenue growth to be in the range of 14-16% (previously 12-15%), while Med Device revenue growth is projected to remain flat over the comparable fiscal 2025 period.

Management expects the tariffs to have a $4-$6 million impact on its overall top-line and segmental performance.

The adjusted loss per share is projected to be between 33 cents and 23 cents, including the tariff impacts (narrower than earlier guidance of a loss of 35 cents to 25 cents). The Zacks Consensus Estimate is currently pegged at a loss of 30 cents per share.

Our Take on ANGOAngioDynamics (ANGO - Free Report) delivered a solid start to fiscal 2026, with first-quarter revenues rising 12.2% year over year, led by continued strength in its Med Tech segment, which grew 26% and now represents nearly half of total sales. The company also reported a narrower-than-expected adjusted loss, supported by gross margin expansion despite the impact of tariff headwinds.

Key growth drivers going forward include the Auryon platform as adoption expands in hospitals and internationally following CE mark approval. Mechanical Thrombectomy, comprising AngioVac and AlphaVac, delivered continued growth fueled by new hospital approvals, strong physician uptake, and a dedicated sales force expansion to 50 reps.

NanoKnife continued to show momentum with probe sales tied largely to prostate procedures. The expanded prostate indication, rising physician interest, and a direct-to-patient AARP campaign are boosting adoption, while the upcoming CPT I reimbursement code, effective Jan. 1, 2026, is expected to further accelerate utilization.

With a favorable revenue mix, pricing actions, and operating efficiencies driving margin gains, AngioDynamics raised its FY26 revenue outlook, signaling confidence in sustained growth and profitability improvement.

AngioDynamics’ Zacks Rank & Key PicksANGO currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space are Masimo (MASI - Free Report) , Phibro Animal Health (PAHC - Free Report) and CorMedix (CRMD - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Masimo shares have jumped 5.3% in the past year. Estimates for the company’s 2025 earnings per share have increased 1.3% to $5.30 in the past 30 days. MASI’s earnings beat estimates in each of the trailing four quarters, the average surprise being 13.8%. In the last reported quarter, it posted an earnings surprise of 8.1%.

Estimates for Phibro Animal Health’s fiscal 2026 earnings per share have increased 6.5% to $2.45 in the past 30 days. Shares of the company have surged 83.3% in the past year compared with the industry’s 0.7% growth. PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 27.9%. In the last reported quarter, it delivered an earnings surprise of 9.6%.

Estimates for CorMedix’s 2025 earnings per share have increased 50% to $1.83 in the past 30 days. Shares of the company have rallied 24.2% in the past year against the industry’s 5.1% decline. Its earnings yield of 16.6% also outpaces the industry’s -20.5% yield. CRMD’s earnings topped estimates in each of the trailing four quarters, the average surprise being 34.9%.

Key Takeaways Hologic gained FDA clearance and CE marking for its Panther Fusion GI bacterial assays.
HOLX shares climbed 1.3% to $67.91 after the approval of the new diagnostic tests.
Hologic's assays detect major GI pathogens, offering faster, more tailored patient testing.

Hologic, Inc. (HOLX - Free Report) recently received FDA 510(k) clearance for its Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. Additionally, the assays obtained CE marking in the European Union in accordance with the In Vitro Diagnostic Regulation.

These highly sensitive molecular tests are designed to rapidly detect the most common bacterial pathogens responsible for infectious gastroenteritis.

Likely Trend of HOLX Stock Following the NewsFollowing the announcement, shares of the company surged 1.3% to $67.91 yesterday.

The company’s Molecular Diagnostics assays, which run on Panther and Panther Fusion systems, remain the principal revenue-generating component in the Diagnostics division. A key catalyst for Diagnostics’ sustained growth is the expanding global installed base of Panther instruments. Accordingly, we expect the latest development to bolster investor confidence and maintain an upward momentum in HOLX's share price in the upcoming days.

Hologic currently has a market capitalization of $15.10 billion. The company’s earnings yield of 6.7% compares favorably to the industry’s -4.3%. It delivered an average earnings surprise of 0.96% for the trailing four quarters.

More on Hologic’s New AssaysTraditionally, identifying pathogens causing severe diarrheal illness has required the combination of culture, biochemical and microscopy-based tests, which can be labor-intensive, time-consuming and less sensitive than molecular methods. Hologic’s new GI pathogen detection tests leverage rapid molecular technology and cover common bacterial causes of infectious gastroenteritis, including Salmonella, Campylobacter, Shigella, E. coli (including O157), Vibrio, Yersinia and Plesiomonas, and can be run together or in any combination. 

In this customizable mini-panel format, the new assays allow testing to be specific and tailored to patients’ needs. This approach also helps reduce testing, streamline lab processes and accelerate time to diagnosis and clinical management. In the long term, it supports antimicrobial stewardship by enabling the judicious use of antibiotics. 

Testing of the Panther Fusion GI Bacterial and Expanded Bacterial Assays is performed using Hologic’s trusted Panther Fusion System, an addition to the Panther System. 

Image Source: Zacks Investment Research

About HOLX’s Panther and Panther Fusion SystemsThe Panther System is a best-in-class, fully automated sample-to-result molecular diagnostics platform suitable for use in low, medium, or high-throughput laboratories. With a small footprint, adaptable workflow options, and a consolidated testing menu, it provides testing for women’s health, sexually transmitted infections, respiratory infections, viral load, transplant viruses, and now infectious gastroenteritis. The Panther Fusion module provides an expanded and growing in vitro diagnostics menu, as well as Open Access functionality, to run laboratory-developed tests. 

Industry Prospects Favor HOLXInfectious gastroenteritis, caused by bacteria, viruses, or parasites, can range from mild to severe. Per researchers, in the United States alone, it is estimated that nearly 200 million cases occur annually, including up to 3 million that require ambulatory visits. Per analysts, foodborne outbreaks across Europe have resulted in the highest numbers of related hospitalizations and deaths recorded in a decade, with Salmonella accounting for the largest proportion of cases. 

Per a report by Persistence Market Research, the global gastrointestinal infection testing market is predicted to reach a size of $467.2 million by 2025. It is anticipated to witness a CAGR of 5.2% during the period to attain a value of $617.7 million by 2032.

Another Development by HOLXHologic unveiled favorable data from two groundbreaking studies evaluating its AI-powered mammography technology, the Genius AI Detection solution, at the European Society of Breast Imaging Annual Scientific Meeting in Aberdeen, Scotland. Research suggests that artificial intelligence may aid in identifying more aggressive forms of breast cancer and demonstrate performance comparable to that of expert radiologists in screening.

HOLX Stock Price PerformanceIn the past year, Hologic’s shares have risen 18.9% compared with the industry’s 2.3% growth.

HOLX’s Zacks Rank & Key PicksHologic currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space are Masimo (MASI - Free Report) , Phibro Animal Health (PAHC - Free Report) and Boston Scientific (BSX - Free Report) . While Masimo and Phibro sport a Zacks Rank #1 (Strong Buy) each, Boston Scientific carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Masimo’s shares have jumped 18.9% in the past year. MASI’s earnings beat estimates in each of the trailing four quarters, the average surprise being 13.8%. 

Shares of Phibro have surged 76.5% in the past year compared with the industry’s 3.4% growth. PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 27.9%.

Shares of Boston Scientific have rallied 16.7% in the past year compared with the industry’s 5.2% growth. BSX’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.1%.

HomeMarketsDavid Solomon says the U.S. economy is in decent shapePublished: Oct. 3, 2025 at 9:30 a.m. ET

Goldman Sachs Chief Executive Officer David Solomon says the ongoing bull market is not keeping him up at night, but he also expects a pullback within a couple of years.

“I sleep very well and am not going to bed every night worried about what will happen next,” he told Bloomberg TV Friday, while hitting on markets, AI and the economy. “I think the opportunities are great. I think they’re very exciting, but I also see complacency around risk-taking, and when that happens ultimately there’ll be some speed bumps and drawdowns.”

Partner CenterMost Popular

October 03, 2025 09:30 ET

 | Source:

Akari Therapeutics Plc

BOSTON and LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced its abstract has been accepted for oral presentation at the 40th Annual SITC Meeting being held November 5-9, 2025 in National Harbor, MD.

Details of the oral presentation are as follows:

Title: A Novel Splicing-Targeted ADC Payload Drives Immune Activation, Synergy with Checkpoint Inhibitors, and Enhanced Therapeutic Potential beyond Cytotoxicity
Presenter: Satyajit Mitra Ph.D., Executive Director, Head of Oncology at Akari Therapeutics
Abstract No: 951
Session: 302 Beyond Cytotoxic Chemotherapy: the Next Generation of ADCs for Immune Modulation
Date and Time: Sunday, November 9, 2025 at 11:05 AM ET
Location: Gaylord National Resort and Convention Center – Ballroom Level – Potomac Ballroom

Poster Presentation: Friday, November 7, 2025
Location: Prince George ABC Exhibit Halls, Gaylord National Resort and Convention Center

For more information about the SITC Annual Meeting, please visit sitcancer.org.

About Akari Therapeutics

Akari Therapeutics is an oncology biotechnology company developing next-generation spliceosome payload antibody drug conjugates (ADCs). Utilizing its innovative ADC discovery platform, the Company has the ability to generate ADC candidates and optimize them based on the desired application to any target of interest. Akari’s lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and with a proprietary linker, delivers its novel PH1 payload directly into the tumor. Unlike current ADCs that use tubulin inhibitors and DNA damaging agents as their payloads, PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. This splicing modulation has been shown in preclinical animal models to induce cancer cell death while activating immune cells to drive robust and durable activity. In preclinical studies, AKTX-101 has shown to have significant activity and prolonged survival, relative to ADCs with traditional payloads. Additionally, AKTX-101 has the potential to be synergistic with checkpoint inhibitors and has demonstrated prolonged survival as both a single agent and in combination with checkpoint inhibitors, as compared to appropriate controls. The Company is generating validating data on its novel payload PH1 to continue advancing its lead asset, as well as other undisclosed targets with this novel payload.

For more information about the Company, please visit www.akaritx.com and connect on X and LinkedIn.

Cautionary Note Regarding Forward-Looking Statements 

This press release includes express or implied forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, about the Company that involve risks and uncertainties relating to future events and the future performance of the Company. Actual events or results may differ materially from these forward-looking statements. Words such as “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “future,” “opportunity” “will likely result,” “target,” variations of such words, and similar expressions or negatives of these words are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Examples of such forward-looking statements include, but are not limited to, express or implied statements regarding the ability of the Company to advance its product candidates for the treatment of cancer and any other diseases, and ultimately bring therapies to patients. These statements are based on the Company’s current plans, estimates and projections. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific. A number of important factors, including those described in this communication, could cause actual results to differ materially from those contemplated in any forward-looking statements. Factors that may affect future results and may cause these forward-looking statements to be inaccurate include, without limitation: the Company’s need for additional capital; the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the business; risks related to global as well as local political and economic conditions, including interest rate and currency exchange rate fluctuations; potential delays or failures related to research and/or development of the Company’s programs or product candidates; risks related to any loss of the Company’s patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for the Company’s product candidates, including as a result of potential tariffs; the nature, timing, cost and possible success and therapeutic applications of product candidates being developed by the Company and/or its collaborators or licensees; the extent to which the results from the research and development programs conducted by the Company, and/or its collaborators or licensees may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; uncertainty of the utilization, market acceptance, and commercial success of the Company’s product candidates; risks related to competition for the Company’s product candidates; and the Company’s ability to successfully develop or commercialize its product candidates. While the foregoing list of factors presented here is considered representative, no list should be considered to be a complete statement of all potential risks and uncertainties. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the SEC, copies of which may be obtained from the SEC’s website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release except as required by law.

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
[email protected] 

Key Takeaways RPM hiked its quarterly dividend 5.9% to 54 cents per share, marking 52 consecutive years of increases.MAP 2025 delivered $185M in annualized savings, supporting EBIT growth and balance sheet strength.Q1 fiscal 2026 sales hit a record $2.11B, up 7.4% year over year, with EBIT rising 2.9% to $337.8M.
RPM International Inc. (RPM - Free Report) has been following an incremental dividend policy since 1974. In line with this strategy, it recently boosted its investors’ sentiments again with a quarterly dividend hike, marking its 52nd consecutive year of cash dividend increase.

The board of directors approved a quarterly cash dividend payout of 54 cents per share ($2.16 per share annually), representing a 5.9% increase from the previous dividend payout of 51 cents ($2.04 per share annually). The amount will be paid out on Oct. 31, 2025, to shareholders of record as of Oct. 20. Based on the closing price of $116.27 per share on Thursday, the stock has a dividend yield of 1.9%.

The company was able to facilitate this decision based on the benefits realized from the efficient execution of its MAP 2025 operational improvement program and robust top-line growth in its first quarter of fiscal 2026.

What Bolstered RPM’s Dividend Hike?RPM has been focusing on its MAP 2025 operational improvement program, which officially concluded on May 31, 2025. Through this strategic initiative, the company was able to reduce costs and improve working capital efficiency, resulting in annualized savings of approximately $185 million, which supported adjusted EBIT growth across the business. These benefits have continued into fiscal 2026, which has been the primary driver of this dividend hike.

Additionally, the robust sales growth during the first quarter of fiscal 2026 has also contributed to the success of this strategic move. RPM highlighted that the successful integration of its business acquisitions was one of the primary drivers of the sales boost. During the fiscal first quarter, RPM witnessed record sales of $2.11 billion, indicating 7.4% year-over-year growth. Also, adjusted EBIT grew 2.9% compared with the prior year to $337.8 million.

The improved profitability and working capital efficiency, mainly attributable to the MAP 2025 initiative, have resulted in a stable and sufficient balance sheet position for RPM since the start of fiscal 2026. As of Aug. 31, 2025, the company had cash and cash equivalents of $297.1 million, up from $231.6 million as of Aug. 31, 2024. Moreover, during the first quarter of fiscal 2026, the company returned $82 million to its shareholders through cash dividends and share repurchases, reflecting 7.4% year-over-year growth.

Image Source: Zacks Investment Research

The company is optimistic that its focus on product diversification, accretive buyouts and operational excellence is expected to further boost its financial position and ensure shareholder value. Even though the market remains unstable and inflation persists, RPM is well-positioned to counter these headwinds in the upcoming period.

RPM Stock Price PerformanceShares of this manufacturer and marketer of a diverse portfolio of specialty chemical products have gained 2.5% in the past three months against the Zacks Chemical - Specialty industry’s 2.4% decline.

Image Source: Zacks Investment Research

The company’s trailing 12-month return on equity (ROE) is indicative of its growth potential and focus on maintaining shareholder value. Its ROE of 24.2% compares favorably with the industry’s 18.7%, indicating greater efficiency in utilizing shareholders’ funds than its peers.

Image Source: Zacks Investment Research

RPM’s Zacks Rank & Key PicksRPM International currently carries a Zacks Rank #3 (Hold).

Here are some better-ranked stocks from the Basic Materials sector.

Methanex Corporation (MEOH - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks Rank #1 stocks here.

The company has a trailing four-quarter earnings surprise of 83.2%, on average. The stock has gained 13.7% in the past three months. The Zacks Consensus Estimate for Methanex’s 2025 sales implies growth of 4.7% while the earnings per share (EPS) indicate a decline of 0.5%, from the year-ago levels.

Agnico Eagle Mines Limited (AEM - Free Report) presently sports a Zacks Rank of 1. The company has a trailing four-quarter earnings surprise of 10%, on average. The stock has moved up 40.1% in the past three months.

The Zacks Consensus Estimate for Agnico Eagle Mines’ 2025 sales and EPS indicates growth of 30.6% and 68.1%, respectively, from the year-ago period’s levels.

Intrepid Potash, Inc. (IPI - Free Report) currently sports a Zacks Rank of 1. The company has a trailing four-quarter negative earnings surprise of 209.4%, on average. The stock has tumbled 20.9% in the past three months.

The Zacks Consensus Estimate for Intrepid Potash’s 2025 sales and EPS indicates an increase of 3.1% and 493.3%, respectively, from the year-ago levels.

In the absence of randomized trials on the effects of acetaminophen, researchers need to use ‘natural experiments' to develop better guidance for patients.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX), one of the world's leading energy companies, will hold its quarterly earnings conference call on Friday, October 31, 2025, at 11:00 a.m. ET (10:00 a.m. CT). Conference Call Information: Date: Friday, October 31, 2025 Time: 11:00 a.m. ET / 10:00 a.m. CT Dial-in # (Listen-only mode): 888-256-9157 Conference ID #: 5158291 Speakers: Mike Wirth – Chairman of the Board & Chief Executive Officer Eimear Bonner – Vice President & Chief F.

BOSTON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) announced today that it will release operating results for the fourth quarter of fiscal 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call and live webcast to review the fourth quarter results beginning at 8:00 am (ET) on Tuesday, November 4, 2025.

The call will be webcast by Notified and may be accessed at Cabot’s website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company’s website at https://cabotog.gcs-web.com/.

ABOUT CABOT CORPORATION
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company’s website at cabotcorp.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.

Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special.
1 877 963-NEWS
jwyckoff at kitco.com

SummaryIntel (INTC) is experiencing renewed investor interest due to rumors of AMD becoming a foundry customer and strong institutional support.INTC's transformation into a US-based foundry is backed by government and Nvidia investments, but fundamentals remain fragile and financials are weak.Valuation is stretched, with a forward P/E above 300x and negative free cash flow, making the stock a high-risk, news-driven bet.I rate INTC a 'Buy with caution'—the stock has multibagger potential if its foundry strategy succeeds, but patience and risk management are essential.Analyst’s Disclosure:I/we have a beneficial long position in the shares of INTC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

NEW YORK--(BUSINESS WIRE)--Zeta Global (NYSE: ZETA), the AI marketing cloud, announced that Grammy Award-winning duo The Chainsmokers (Alex Pall and Drew Taggart) will join Zeta Live 2025 on October 9 for a keynote conversation exploring how artificial intelligence is reshaping music, collaboration, and culture. In addition to their success as artists, Pall and Taggart are co-founders of Mantis, a venture capital firm with more than 130 investments at the intersection of technology, consumer innovation, and culture, adding an entrepreneurial lens to their perspective on innovation.

Expanding on the speaker lineup already announced, Zeta Live 2025 will feature additional powerhouse voices from sports, consulting, retail, and consumer goods. Legendary tennis champion and cultural icon Stan Smith will join the agenda, along with Kim Perell, nine-time founder and best-selling author; Allen Weinberg, Director at McKinsey; Jill Cress, Chief Marketing and Experience Officer at H&R Block; Alex Frias, Chief Marketing Officer at Steve Madden; and Chad Stubbs, Chief Marketing Officer at Ferrero North America. Across their sessions, these speakers will address themes spanning AI’s role in unlocking marketing performance, shaping the creative edge for CMOs, advancing human collaboration, and redefining the future of customer connection.

At 4 p.m. ET, Pall and Taggart will take the stage for a session titled “Sampling the Future: AI, Music, and Culture.” Moderated by Zeta Co-Founder, Chairman and CEO David A. Steinberg, the conversation will explore how AI is turning audiences into co-creators and redefining fandom. They will also discuss how brands can plug into culture and strengthen human connection through technology. As artists and investors through Mantis, they bring a unique dual perspective on how creativity and business intersect in an AI-driven world.

Following the session, The Chainsmokers will perform live at an exclusive offsite event.

“Zeta Live continues to grow as a platform where the most influential voices in culture, technology and business come together. This expansion reflects our commitment to showcasing perspectives that spark new ideas in creativity, innovation and AI, and inspiring leaders to connect with consumers in fresh ways,” said Steinberg.

Zeta Live 2025 will be held on October 9 in New York City. The conference will bring together more than 1,200 senior marketers, 70 speakers from leading brands such as AWS, Marriott, United Airlines and Nissan, and over 25 sessions across three stages. This year’s theme, “Achieve the Impossible,” will feature headliners from legendary athletes alongside leaders in business, media and technology.

For the full agenda and to register, visit www.zetalive2025.com.

About Zeta Global

Zeta Global (NYSE: ZETA) is the AI Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers to acquire, grow, and retain customers more efficiently. Through the Zeta Marketing Platform (ZMP), our vision is to make sophisticated marketing simple by unifying identity, intelligence, and omnichannel activation into a single platform – powered by one of the industry’s largest proprietary databases and AI. Our enterprise customers across multiple verticals are empowered to personalize experiences with consumers at an individual level across every channel, delivering better results for marketing programs. Zeta was founded in 2007 by David A. Steinberg and John Sculley and is headquartered in New York City with offices around the world. To learn more, go to www.zetaglobal.com.

Forward-Looking Statements

This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Any statements made in this press release that are not statements of historical fact are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning our anticipated future financial performance, our market opportunities and our expectations regarding our business plan and strategies. These statements often include words such as “anticipate,” “believe,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intend,” “may,” “outlook,” “plan,” “projects,” “should,” “suggests,” “targets,” “will,” “would” and other similar expressions. We base these forward-looking statements on our current expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at such time. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our business, results of operations and financial condition and could cause actual results to differ materially from those expressed in the forward-looking statements. These statements are not guarantees of future performance or results.

The forward-looking statements are subject to and involve risks, uncertainties and assumptions, and you should not place undue reliance on these forward-looking statements. These cautionary statements should not be construed by you to be exhaustive and the forward-looking statements are made only as of the date of this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

October 03, 2025 08:30 ET

 | Source:

KraneShares

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cambricon Technologies Corporation Limited (“Cambricon”), often described as “China's answer to Nvidia1,” has been one of the standout performers on Shanghai’s Science & Technology Innovation Board (“STAR Market”) in 2025.

Cambricon’s shares have gained about ~111% year-to-date amid strong revenue growth (+4,347.8% year-over-year as of 6/30/2025) and profitability milestones (Net income went from a RMB -545.3 million net loss in H1 2024 to RMB +1.04 billion net profit in H1 2025).2 U.S. investors seeking exposure to Cambricon and other STAR companies can consider the KraneShares SSE STAR Market 50 Index ETF (NYSE: KSTR)—the only U.S.-listed ETF that tracks the SSE STAR Market 50 Index.3

Founded in 2016, Cambricon designs AI chips for cloud, edge, and terminal applications. The STAR Market—often likened to a Nasdaq-style venue because of its focus on high-tech and strategic emerging industries like next-generation information technology, biomedicine, high-end equipment, and similar industries—serves as a platform for high-growth science and technology firms.

“Cambricon’s rapid ascent speaks to the scale and speed of innovation across China’s semiconductor and AI industries,” said Brendan Ahern, Chief Investment Officer at KraneShares. “Through KSTR, investors can gain exposure to STAR Market companies—including Cambricon—within a regulated, U.S.-listed vehicle.”

Launched on January 26, 2021, KSTR provides exposure to up to 50 companies that meet market capitalization and liquidity requirements listed on the STAR Market, connecting investors to China’s next generation of innovators across semiconductors, next-gen IT, biotech, and new energy. KSTR is the only U.S.-listed ETF licensing the SSE STAR 50 Index.3

KSTR Performance (YTD): As of the most recent data available, KSTR is up ~48% year-to-date.2

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed or sold, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. For performance data current to the last month-end, please visit https://kraneshares.com/kstr.

For top 10 holdings, risks, and other important information about the KraneShares SSE STAR Market 50 Index ETF (Ticker: KSTR), please visit https://kraneshares.com/kstr.

High short-term performance from a limited number of the fund’s holdings is unusual, and investors should not expect such performance to be continued over the long term. Past performance does not guarantee future results.

Cambricon represents 12.55% of the fund (KSTR) as of 9/25/2025. Holdings are subject to change.

About KraneShares

KraneShares is a specialist investment manager focused on delivering global investors innovative, high-conviction strategies. The firm is known for its China-focused and climate-focused ETFs, as well as its solutions across emerging markets, carbon allowances, options income, and disruptive technologies like artificial intelligence and electric vehicles. KraneShares helps investors access transformative growth opportunities through research-driven products and educational resources.

For more information, visit www.kraneshares.com.

Citations:

Reuters, “China investors seen looking past Cambricon index rebalance, staying bullish on AI,” as of 9/12/2025. Link: https://www.reuters.com/world/china/china-investors-seen-looking-past-cambricon-index-rebalance-staying-bullish-ai-2025-09-12/.Data from Bloomberg as of 9/25/2025.Data from Bloomberg as of 9/22/2025. Definitions:

Revenue: The total amount of money generated by a company from its business activities, such as sales of goods or services, before any expenses are deducted.

Net income: Accounts for all revenues and subtracts all expenses, including cost of goods sold, operating expenses, interest, and taxes. It reflects the true bottom-line profit available to shareholders and provides the most comprehensive measure of profitability.

Carefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds’ full and summary prospectus, which may be obtained by visiting www.kraneshares.com/kstr. Read the prospectus carefully before investing.

Risk Disclosures:

Investing involves risk, including possible loss of principal. There can be no assurance that a Fund will achieve its stated objectives. Indices are unmanaged and do not include the effect of fees. One cannot invest directly in an index.

This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. Certain content represents an assessment of the market environment at a specific time and is not intended to be a forecast of future events or a guarantee of future results; material is as of the dates noted and is subject to change without notice.

A-Shares are issued by companies in mainland China and traded on local exchanges. They are available to domestic and certain foreign investors, including QFIs and those participating in Stock Connect Programs like Shanghai-Hong Kong and Shenzhen-Hong Kong. Foreign investments in A-Shares face various regulations and restrictions, including limits on asset repatriation. A-Shares may experience frequent trading halts and illiquidity, which can lead to volatility in KSTR’s share price and increased trading halt risks. The Chinese economy is an emerging market, vulnerable to domestic and regional economic and political changes, often showing more volatility than developed markets. Chinese companies face risks from potential government interventions, and the export-driven economy is sensitive to downturns in key trading partners, impacting KSTR. U.S.-China tensions raise concerns over tariffs and trade restrictions, which could harm China’s exports and KSTR. China's regulatory standards are less stringent than in the U.S., resulting in limited information about issuers. Tax laws are unclear and subject to change, potentially impacting KSTR and leading to unexpected liabilities for foreign investors. Fluctuations in currency of foreign countries may have an adverse effect to domestic currency values.

KSTR may invest in derivatives, which are often more volatile than other investments and may magnify KSTR's gains or losses. A derivative (i.e., futures/forward contracts, swaps, and options) is a contract that derives its value from the performance of an underlying asset. The primary risk of derivatives is that changes in the asset’s market value and the derivative may not be proportionate, and some derivatives can have the potential for unlimited losses. Derivatives are also subject to liquidity and counterparty risk. KSTR is subject to liquidity risk, meaning that certain investments may become difficult to purchase or sell at a reasonable time and price. If a transaction for these securities is large, it may not be possible to initiate, which may cause KSTR to suffer losses. Counterparty risk is the risk of loss in the event that the counterparty to an agreement fails to make required payments or otherwise comply with the terms of the derivative.

KSTR may invest in Initial Public Offerings (IPOs). Securities issued in IPOs have no trading history, and information about the companies may be available for very limited periods. In addition, the prices of securities sold in IPOs may be highly volatile. In addition, as KSTR increases in size, the impact of IPOs on KSTR’s performance will generally decrease. Narrowly focused investments typically exhibit higher volatility. KSTR’s assets are expected to be concentrated in a sector, industry, market, or group of concentrations to the extent that the Underlying Index has such concentrations. The securities or futures in that concentration could react similarly to market developments. Thus, KSTR is subject to loss due to adverse occurrences that affect that concentration. In addition to the normal risks associated with investing, investments in smaller companies typically exhibit higher volatility. KSTR is non-diversified.

ETF shares are bought and sold on an exchange at market price (not NAV) and are not individually redeemed from the Fund. However, shares may be redeemed at NAV directly by certain authorized broker-dealers (Authorized Participants) in very large creation/redemption units. The returns shown do not represent the returns you would receive if you traded shares at other times. Shares may trade at a premium or discount to their NAV in the secondary market. Brokerage commissions will reduce returns. Beginning 12/23/2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates the current NAV per share. Prior to that date, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time.

The KraneShares ETFs and KFA Funds ETFs are distributed by SEI Investments Distribution Company (SIDCO), 1 Freedom Valley Drive, Oaks, PA 19456, which is not affiliated with Krane Funds Advisors, LLC, the Investment Adviser for the Funds, or any sub-advisers for the Funds.

Contact:
KraneShares Investor Relations
[email protected]

New York, NY, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (the “Company,” “we,” “us,” “our company,” or “MFH”) (Nasdaq: MFH), a blockchain-native fintech company, today announced the publication of a new article by MFH Chief Strategy Officer Wilfred Daye examining digital asset treasury strategies and their associated risks.

Published by CoinsPaid Media on September 24, 2025, “Digital Asset Treasuries: Engineering Yield in a Frothy Market” analyzes how Digital Asset Treasury (DAT) companies leverage market-to-net-asset-value dynamics, convertible securities, and preferred stock to accumulate Bitcoin, while identifying key risks including market-to-net-asset-value ratio (mNAV) compression, refinancing exposure, and index-eligibility considerations. The article also reflects MFH’s own approach to digital asset treasury management in the current market environment.

“Digital asset treasuries are evolving from a simple ‘buy-and-hold’ posture into a capital markets discipline that must balance access, liquidity, and risk,” said Daye. “Our goal is to align treasury design with institutional-grade safeguards, clear risk limits, transparent disclosures, and diversified liquidity so that participation in the asset class is both responsible and durable.”

“Wilfred’s piece distills what responsible DAT design should look like,” said Shi Qiu, Chief Executive Officer of MFH. “MFH’s north star is to connect traditional finance with crypto-native assets through compliant structures, prudent balance-sheet management, and investor-first transparency.”

MFH Treasury & Capital-Markets Principles:

Risk-aware accumulation: Use market windows judiciously; avoid shareholder-value-destructive issuance when mNAV conditions are unfavorable.Financing discipline: Treat convertible securities and preferred stock as leverage tools with explicit guardrails and contingency plans.Liquidity and transparency: Prioritize exchange liquidity, robust disclosures, and auditability suitable for institutional allocators.Evolution beyond Bitcoin beta: Invest in infrastructure and partnerships that create operating revenue and reduce reliance on a single-factor market cycle. About Mercurity Fintech Holding Inc. 
Mercurity Fintech Holding Inc. (Nasdaq: MFH) is a fintech group powered by blockchain infrastructure, offering technology and financial services. Through its subsidiaries, including Chaince Securities, LLC, MFH aims to bridge traditional finance and digital innovation, offering services spanning digital assets, financial advisory, and capital markets solutions.

Forward-Looking Statements
This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results.

Contacts:
International Elite Capital Inc.
Annabelle Zhang
Tel: +1(646) 866-7928
Email: [email protected]

October 03, 2025 08:30 ET

 | Source:

Alico, Inc.

FORT MYERS, Fla., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company’s President and Chief Executive Officer, will present and host one-on-one meetings with investors at the 19th annual Main Event, taking place on October 19-21st of 2025 at the Hotel del Coronado in San Diego, CA.

The presentation will begin at 2:30 PM ET on Monday, October 20th, 2025 and can be accessed live here. Management will also host one-on-one meetings with investors on Monday, October 20th and Tuesday, October 21st, 2025. To register for the presentation or one-on-one meeting, visit here.

Summary of LD Micro Main Event XIX

The 2025 LD Micro Main Event XIX will run from October 19th to the 21st at the Hotel del Coronado in San Diego, California. The first day will consist of registration, keynote speakers, and some gorgeous views of the Pacific. It will be followed by two full days of company presentations and one-on-one investor meetings concluded with a closing reception. This three-day event will feature around 120 companies, presenting in half-hour increments, and attending private meetings with investors.

About Alico

Alico, Inc. (Nasdaq: ALCO) is a Florida-based agribusiness and land management company with over 125 years of experience. Following its strategic transformation in 2025, Alico operates as a diversified land company with approximately 51,300 acres across 8 Florida counties. The Company focuses on strategic land development opportunities and diversified agricultural operations, leveraging its extensive land portfolio to create long-term shareholder value while maintaining its commitment to responsible land stewardship and conservation. Learn more about Alico at www.alicoinc.com.

About LD Micro

LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro’s mission is to provide unparalleled access and insight for those seeking the next generation of great companies. To learn more about LD Micro, visit: http://www.ldmicro.com

Investor Contact:
John Mills
ICR
(646) 277-1254
[email protected]

Brad Heine
Chief Financial Officer
(239) 226-2000
[email protected]

October 3, 2025  - TheNewswire - Vancouver, BC - New Age Metals Inc. (TSX.V: NAM; OTCQB: NMTLF; FSE: P7J.F) (“NAM” or the “Company”) announces that the Company has closed the first tranche of a non brokered private placement financing by issuing 1,730,771 flow-through units (“FT Units”) at a price of $0.26 per FT Unit and issuing 9,090,910 non-flow-through units (“NFT Units”) for aggregate gross proceeds in the first tranche of $2,450,000.

Each FT Unit consisted of one flow-through common share of the Company and one half of one share purchase warrant.  Each whole warrant entitles the holder thereof to purchase one additional common share of the Company at an exercise price of $0.40 per share, for a period of three years from closing.

Each NFT Unit consisted of one common share of the Company and one half of one share purchase warrant. Each whole warrant entitling the holder thereof to purchase one additional common share of the Company at an exercise price of $0.40 per share for a period of three years from closing.

Finder’s fees in the aggregate amount of $27,000.02 in cash and 142,307 non-transferable finder warrants were paid to GloRes Securities Inc. and PB Markets Inc. in connection with the FT Unit tranche closing. The finder warrants are exercisable at a price of $0.26 per share for a period of three years from closing. No finder fees were paid in connection with the NFT Units.

The foregoing is subject to TSX Venture Exchange (“Exchange”) approval. All securities issued in connection with the first tranche closing are subject to a four-month and a day hold period expiring February 4, 2026 in accordance with applicable Canadian Securities laws.

The proceeds of the FT Unit private placement will be used for exploration and development of the Company’s projects located in Newfoundland, Ontario and Manitoba. Proceeds of the NFT Units will be used for exploration and general working capital. Completion of the private placement and any Finder Fees payable are subject to all necessary regulatory approvals.

Mr. Eric Sprott, through 2176423 Ontario Ltd., a corporation which is beneficially owned by him, acquired 9,090,910 Units for $0.22 per Unit for a total consideration of $2,000,000.20. Prior to the Private Placement, Mr. Sprott beneficially owned or controlled 12,875,000 Common Shares representing approximately 23.2% of the outstanding Shares on a non-diluted basis. Following the completion of the Private Placement, Mr. Sprott beneficially owns and controls 21,965,910 Common Shares and 4,545,455 warrants representing approximately 33.1% of the outstanding Shares on a non-diluted basis and 37.4% on a partially-diluted basis assuming the exercise of such warrants.

The Units were acquired by Sprott for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities of the Company including on the open market or through private acquisitions or sell securities of the Company including on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.

A copy of Sprott's early warning report will appear on New Age Metals’ profile on SEDAR+ and may also be obtained by calling Mr. Sprott’s office at (416) 945-3294 (1106-7 King Street East, Toronto, ON, M5C 3C5).

2176423 Ontario Ltd. (Eric Sprott) an existing insider and control person of the Company purchased 9,090,910 NFT Units of the Offering, which is considered a related party transaction within the meaning of Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions) (“MI 61-101”) and TSX Venture Exchange Policy 5.9 (which incorporates by reference MI 61-101). The Company relied on exemptions from the formal valuation and minority shareholder approval requirements under sections 5.5(a) and 5.7(1)(a), respectively, of MI 61-101, as neither the fair market value of the NFT Units to be purchased on behalf of insiders nor the consideration to be paid by insiders exceeded 25% of the Company's market capitalization. A material change report will be filed fewer than 21 days prior to the closing of the Offering. The Company did not file a material change report 21 days before closing of the offerings as the details of insider participation were not known at that time.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration, and development of critical green and precious metal projects in North America. The Company has four divisions: a Platinum Group Element division, Gold Division, a Lithium/Rare Element division, an Antimony-Gold Division as well as an investment in MetalQuest Mining’s (TSXV:MQM | OTC:MQMIF) a high purity Lac Otelnuk Iron Ore Project.

The PGE Division includes the 100% owned, multi-million-ounce, district-scale River Valley Project, one of North America’s largest undeveloped Platinum Group Element Projects, situated 100 km by road east of Sudbury, Ontario. In addition to River Valley, NAM owns 100% of the Genesis PGE-Cu-Ni Project in Alaska.

On October 1st 2025, the Company announced that it has entered into agreement to option the Bonanza Gold Project, located in the Kenora Gold District. The Project consists of 114 mining claims and 1 patented Mining Claim totalling 2,191 hectares or 5,414 acres. The Project has multiple high-grade mineral occurrences with spectacular visible gold at surface along with excellent infrastructure including road access to all areas of the Project along with provincial grid power lines. The Kenora Gold District is known for its high-grade Archean lode-gold deposits, the district has supported mineral exploration and some mining  for more than a century. Some of the active majors and mid-tier companies in the District are Agnico Eagle, Kinross, Centerra and New Gold. NAM’s technical team is currently working on the exploration plan and budget for the balance of 2025 and for 2026. Further announcements on the Bonanza Gold Project will b forth coming.

The Company’s Lithium Division is one of the largest mineral claim holders in the Winnipeg River Pegmatite Field, where the Company is exploring hard rock lithium and various rare elements such as tantalum, rubidium, and cesium. NAM is developing its lithium division in conjunction with its Farm-in/Joint Venture agreement with Mineral Resources Ltd. (“MinRes”), one of the world’s largest lithium producers. A minimum budget to maintain the Projects has been approved by Mineral Resources Ltd for May 2025 to April 2026. The Companies agreed to the minimum budget due to current lithium pricing and forest fire dangers in the immediate area

In April 2024, a $1.5M NSERC Alliance grant was awarded to a collaboration led by the University of Manitoba (Drs. Fayek and Camacho), with academic partners from Lakehead University (Dr. Hollings) and industry partners including New Age Metals and Grid Metals. This research is focused on advancing Canada’s critical metals sector, with New Age Metals’ portion targeting its Bird River lithium properties. Approximately $107,000 of work is planned on New Age’s properties in 2025. The early work will include core sampling and field visits starting this summer. The project will likely extend beyond the original 3-year term, due to its delayed start.

New Age Metals Inc. is supporting a successful $180K Mitacs research grant, awarded in 2023, through its $90K contribution (already accounted for and paid under the Mineral Resources joint venture). This academic partnership with the University of New Brunswick and the University of British Columbia is focused on understanding the origin and controls of lithium pegmatite mineralization in the Cat Lake–Winnipeg River field. Fieldwork for the MSc. thesis has been completed, while the post-doctoral phase is ongoing at UNB. This collaboration provides access to top-tier scientific expertise and equipment, significantly reducing analysis costs and adding long-term value to the project.

NAM’s Antimony-Gold division is in Newfoundland and spans over 19,800 hectares consisting of 11 non-contiguous properties. Six of these properties are in St. Alban’s area, along Canstar’s Swanger and Little River mineralized trends. The remaining 5 properties are strategically located along the same geological trend as the past-producing Beaver Brook Antimony Mine and in proximity to New Found Gold’s Queensway South Gold Project. Management has recently completed Phase 1 of the Project, Phase 2 has been initiated, and further news will follow. On July 30th, the Company was pleased to announce that it has received formal approval under Newfoundland and Labrador’s Junior Exploration Assistance (JEA) Program, including eligibility for the Critical Minerals Assistance (CMA) and Provincial Critical Mineral Assistance (PCMA) streams. The potential rebate total for eligible exploration activities is $71,975.

On August 6, 2025, New Age Metals announced an additional investment in a 4th critical metal. NAM currently owns approximately 12.79% and holds warrants that, if exercised with today’s issued and outstanding shares of MQM, would bring NAM to a 19.05% interest in MetalQuest Mining inc.

MetalQuest Mining inc. is developing one of North Americas largest iron ore projects, where approximately $120 million has been spent on the project. For more information, please visit MetalQuestMining.com . High-purity iron ore became a critical metal Federally in Canada and in the Provinces of Quebec and Newfoundland and Labrador in 2024. In the summer of 2025, MQM has contracted AtkinsRealis, an international engineering company, to complete a GAP Analysis on the Lac Otelnuk Project and its 2015 Feasibility Study.

Management is currently aggressively seeking new mineral acquisition opportunities on an international scale. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production

The Company is actively seeking an option/joint venture partner for our and its road-accessible Genesis PGE-Cu-Ni Project in Alaska.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Farid Mammadov at [email protected] or call 613 659 2773.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

On behalf of the Board of Directors

“Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR+ (www.sedarplus.ca), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

, /PRNewswire/ -- Flagstar Financial, Inc. (NYSE: FLG) (the "Company") today announced that it plans to issue results for the three and nine months ended September 30, 2025 at approximately 6:00 a.m. Eastern Time (ET) on Friday, October 24, 2025. The earnings release and presentation will be posted to the Investor Relations portion of the Company's website, ir.flagstar.com shortly after issuance. 

The Company will conduct a conference call at 8:00 a.m. (ET) on the same date, during which Chairman, President, and Chief Executive Officer, Joseph M. Otting and Senior Executive Vice President and Chief Financial Officer, Lee Smith will discuss the Company's third quarter 2025 performance.

Conference Call Dial-In Instructions :
Once you dial-in to the call, please enter the conference ID (5857240) and press #.  You will then be prompted to provide your name and company name before being placed directly into the call.  Participants should dial-in at least 15 minutes in advance of the call start time. 

The conference call will be simultaneously webcast at ir.flagstar.com and archived through 5:00 p.m. on November 21, 2025.

Conference Call Details :

Conference ID: 

5857240

Dial-in for Live Call:

Domestic   

(888) 596-4144

International

(646) 968-2525

Dial-in for Replay:

Availability   

October 24 (11:00 a.m.) – October 28 (11:59 p.m.)

Domestic     

(800) 770-2030

International

(609) 800-9909

About Flagstar Financial, Inc.

Flagstar Financial, Inc. is the parent company of Flagstar Bank, N.A., one of the largest regional banks in the country. The Company is headquartered in Hicksville, New York. At June 30, 2025, the Company had $92.2 billion of assets, $64.4 billion of loans, deposits of $69.7 billion, and total stockholders' equity of $8.1 billion. Flagstar Bank, N.A. operates approximately 360 locations across nine states, with strong footholds in the greater New York/New Jersey metropolitan region and in the upper Midwest, along with a significant presence in fast-growing markets in Florida and the West Coast.

Investor Contact:
Salvatore J. DiMartino
(516) 683-4286

Media Contact:   
Steven Bodakowski
(248) 312-5872

SOURCE Flagstar Financial, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Over the past ten years, Qualcomm (NASDAQ:QCOM) has distributed an impressive $87 billion to its shareholders in the form of cash through dividends and buybacks. Behind the cash machine lies Qualcomm’s dual powerhouses — its technology licensing juggernaut that almost every wireless player depends on, and its mobile chipset franchise that remains the standard-bearer for the industry.

A man uses his mobile phone near a Qualcomm stall at the China International Fair for Trade in Services (CIFTIS) in Beijing on September 4, 2023. (Photo by WANG Zhao / AFP) (Photo by WANG ZHAO/AFP via Getty Images)

AFP via Getty Images

Let’s examine some figures and see how this payout capability compares to the leading capital-returning companies in the market. related: How QCOM Stock Doubles To $360

Interestingly, QCOM holds the position of the 22nd highest amount returned to shareholders in history.

Returns

Trefis

Why is this important? Dividends and share buybacks represent direct, tangible returns to capital for shareholders. They also indicate management's confidence in the company's financial stability and capacity to generate sustainable cash flows. There are numerous companies with similar attributes. Here is a list of the top 10 businesses ranked by total capital returned to shareholders through dividends and stock repurchases.

Top 10 Companies By Total Shareholder Return

Comparison

Trefis

For the complete ranking, visit Buybacks & Dividends Ranking

What observations can you make here? The total capital returned to shareholders as a percentage of the current market cap seems to be inversely related to growth prospects for reinvestments. Companies such as META and MSFT are experiencing much more rapid growth in a more predictable manner compared to others, yet they have returned a smaller portion of their market capitalization to shareholders.

This illustrates the trade-off when it comes to high capital returns. While those returns are appealing, one must consider: Am I compromising growth and sound fundamentals? With that in mind, let's analyze some figures for QCOM. (See Buy or Sell QCOM Stock for further details)

QCOM Fundamentals

Revenue Growth: 15.8% LTM and 1.4% last 3-year average.Cash Generation: Nearly 26.9% free cash flow margin and 27.8% operating margin LTM.Recent Revenue Shocks: The lowest annual revenue growth in the last 3 years for QCOM was -8.4%.Valuation: QCOM trades at a P/E multiple of 15.7Opportunity vs S&P: Compared to the S&P, QCOM offers lower valuation, greater LTM revenue growth, and superior marginsS&P

Trefis

This summary provides a solid overview, but assessing a stock from an investment viewpoint entails much more. This is precisely what Trefis High Quality Portfolio accomplishes. It aims to minimize stock-specific risk while allowing upside participation.

QCOM Historical Risk

However, QCOM is not exempt from significant declines. It experienced a drop of nearly 79% during the Dot-Com crash, fell approximately 48% during the Global Financial Crisis, and saw a decrease of around 44% in the inflation shock. Even smaller declines like those in 2018 and during the Covid pandemic resulted in over 30% losses each time. Strong fundamentals are vital, but when the market shifts, QCOM can still suffer a substantial blow.

Yet, the risk is not restricted to major market downturns. Stocks can decline even amidst strong markets—consider events such as earnings announcements, business updates, and changes in outlook. Check QCOM Dip Buyer Analyses to understand how the stock has bounced back from significant drops in the past.

The Trefis High Quality (HQ) Portfolio, consisting of 30 stocks, has a history of consistently outperforming its benchmark, which includes all three – S&P 500, S&P mid-cap, and Russell 2000 indices —and has achieved returns exceeding 91% since its inception. Why is this so? Collectively, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; it’s a smoother investment experience, as evidenced by HQ Portfolio performance metrics.

Crypto exchange-traded funds (ETFs) are continuing their positive streak this week, recording consistent green daily inflows since September 26.

As usual, BlackRock is dominating the landscape, having seen approximately $446 million in Bitcoin (BTC) and $177 million in Ethereum (ETH) inflows, or around $623 million in total, on Thursday, October 2, according to data retrieved by Finbold from SoSoValue.

With the fresh capital, the world’s largest fund now has nearly $111.5 billion in the two assets, Bitcoin accounting for 84% of its overall holdings and Ethereum for about 14%. 

Daily volumes are likewise strong, with $4.25 billion traded in the last 24 hours, as the total Bitcoin ETF market capitalization hovers at some $161 billion.

BlackRock BTC and ETH inflows. Source: SoSoValue
Institutional appetite for BTC and ETH grows
U.S. spot Bitcoin ETFs are regaining momentum after a brief cooldown in late September, with renewed capital signaling renewed investor confidence at the start of “Uptober.” 

In addition to BlackRock, Fidelity and ARK also posted some gains, the former recording $89.62 million and the latter $45.18 million in inflows on the same day, bringing the total cumulative net inflow to $59.07 billion.

Ethereum ETFs were also strong, as Fidelity and Bitwise saw $60.71 million and $46.47 million added, respectively. What’s more, only two of the nine products, Franklin and Invesco, recorded no positive net changes.

Big-money investors remain drawn to ETFs for their regulated structure, so the surge in ETF demand highlights the crypto’s accelerating appeal, as even long-known skeptics are starting to rethink their positions.

Bitcoin continues to trade over $120,450 at the time of writing, up over 10% this week, while Ethereum is holding steady at around $4,481, having gained more than 15% over the same period. 

BTC and ETH weekly price. Source: Finbold
Both assets thus appear bullish, with analysts at Citigroup raising their year-end targets for Bitcoin at $132,000 and Ethereum at $4,500 on October 2. 

Featured image via Shutterstock

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Friday’s crypto market opens on a knife's edge. Bitcoin's price is at $120,091, up 1.2%, and the total market capitalization is close to $2.7 trillion.

One thing to watch today is the Deribit expiry of $3.35 billions in BTC contracts. These contracts could reach a maximum pain zone of $115,000. With all that leverage, strong inflows and expiry pressure, it is set to be a volatile start to U.S. trading.

Bitcoin bulls defend $120,000 despite $14.7 billion liquidation riskBitcoin is holding strong at over $120,000, which is now acting like a support level, both emotionally and technically. Expiry flows are focused on $115,000, with dealers keeping an eye on whether the price moves closer to that before expiration.

HOT Stories

If the bulls hold $118,000-$120,000, we could see upside open toward $122,000-$125,000 into the weekend. Failure, though, could lead to a chain reaction of liquidations. CoinGlass maps show the scale: if BTC drops to $106,500, it would wipe out nearly $15 billion in long positions.

The market is split between leverage pressure and real demand. While futures positioning is overextended, spot flows remain strong. This is a classic setup for mega squeezes in either direction once expiry clears.

Ethereum faces $969 million expiry as $4,200 anchor holdsMeanwhile, Ethereum is selling for $4,460, on its way to $4,500, as the market gets more and more volatile. Deribit's option concentration sits at $4,200, which is right around what a lot of dealers think ETH will end up at.

Above $4,500, the upside opens to $4,700-$4,800. But there is a lot of risk involved in liquidating these holdings. CoinGlass shows that if the price dips to $3,880, there are $10.2 billion in ETH longs that would be exposed. So, if the price drops below $4,171, it could speed up that slide, sending ETH below $4,000.

ETFs are still supporting ETH's base, but the short-term drivers are expiry dynamics and Bitcoin's direction. If BTC loses its footing, ETH could unwind faster because of its leverage load.

Ripple director unveils XRP privacy roadmap for 2026J. Ayo Akinyele, Ripple's Senior Director of Engineering, shared a bold plan to integrate native privacy features into the XRP Ledger by 2026.

The roadmap introduces confidential multi-purpose tokens (MPTs), secure enclaves to prevent frontrunning, and zero-knowledge proofs to allow compliance without revealing sensitive data. 

“Without privacy, financial institutions cannot safely use public ledgers. Without accountability, regulators cannot sign off. With programmable privacy, we can have both.” https://t.co/fo83mCmhCW

Meet J. Ayo Akinyele @ja_akinyele, cryptographer and RippleX Senior Director of…

— RippleX (@RippleXDev) October 2, 2025 As Akinyele points out, privacy is not secrecy for bad actors but the same baseline protection that underpins traditional banking.

By adding these tools to XRPL, Ripple aims to position XRP as the first public ledger combining transparency and institutional-grade confidentiality. With trillions in assets expected to move on-chain, programmable privacy is key to DeFi adoption.

Chart of the day: Shiba Inu's October setup points to 11% upsideShiba Inu (SHIB) is stable at $0.00001244, just above the low it hit in September. The chart is interesting for two reasons: a tight Bollinger squeeze to $0.00001410, and October's impact on SHIB's price.

In 2021, October was the month in which SHIB exploded +833% and made its way into the global top 10. In 2023, it had a modest gain of +6.04%, and in 2024 it still found room for +2.46% despite a stagnant backdrop. If you add it all up, October looks less like a coincidence and more like the meme coin's unofficial earnings season.

SHIB/USD by TradingViewThe setup today is cleaner: liquidity is concentrated between $0.00001200 and $0.00001410, leaving little middle ground. Either SHIB surges and brings meme coin traders back into the mix, or it dips below support and October's narrative implodes before it even starts. For a token based on feelings, the season might matter as much as any chart pattern.

Evening outlookAs for the evening outlook, everyone is keeping an eye on Bitcoin's price, which is in the range of $118,000 to $120,000. A strong defense keeps the Uptober narrative alive, but if it dips below $118K, we might see a rush to the $115K pain zone.

Ethereum's short-term future depends on $4,200. If it holds, ETH could go up to around $4,500-$4,700. But if it drops, the main altcoin might dip down to $3,900.

Altcoins are still pretty selective. PancakeSwap (CAKE) is up 28%, ETHFI is up 14% and meme coins and privacy narratives are all over the headlines. With the SEC in limbo because of the shutdown, the focus is on BTC and ETH's expiry, SHIB's October setup and Ripple's XRP privacy push.

Aptos price has confirmed a bullish reversal pattern amid new ecosystem partnerships.

Summary

Aptos price is up 30% over the past 7 days.
World Liberty Financial has launched its stablecoin USD1 on Aptos.
The total value locked and stablecoin supply on Aptos has increased noticeably.

According to data from crypto.news, Aptos (APT) was trading at $5.12 on Oct. 3 afternoon Asian time, up 5% over the past 24 hours and 30% over the last 7 days. 

The token’s daily trading volume peaked at nearly $1.2 billion today, almost double the level seen at the start of the period, showing robust demand from traders. 

Investor interest has also been notable in the derivatives market. According to DeFiLlama, open interest in APT futures climbed from $323 million to more than $436 million at the time of writing, while the weighted funding rate turned positive, both signs that a larger number of traders are starting to open long positions as they remain bullish on the token’s future outlook.

A slew of catalysts have been supporting the tokens’ gains in recent days.

First, Aptos has recently announced a partnership with World Liberty Financial (WLFI) that will bring the USD1 stablecoin to the Aptos blockchain. The launch is scheduled for Oct. 6.

With USD1 currently the sixth-largest stablecoin by market cap at around $2.7 billion, its launch is expected to significantly enhance Aptos’ position in the DeFi space by attracting more trading, lending, and liquidity provision activity to its ecosystem.

Second, Backpack, a multichain wallet and app platform, has introduced native support for Aptos. The development could help boost Aptos adoption as it lowers entry barriers for new users.

At the same time, DeFiLlama data shows that rapid growth in Aptos-based DeFi protocols has pushed the total value locked on the Aptos blockchain from $28 billion in April to over $75 billion at press time. The stablecoin supply on the network has also climbed 5% in the past seven days, reaching $1.09 billion.

On Aptos, the rise in TVL alongside the expanding stablecoin base is a sign that users are not just parking assets temporarily but are actively engaging with the network’s lending protocols, liquidity pools, and decentralized exchanges.

Finally, the broader market rally, coinciding with October’s historical trend as a bullish month for Bitcoin and the crypto market as a whole, has also kept any sort of bearish pressure at bay.

At press time, the crypto Fear and Greed Index had moved into the greed zone, up from fear just a week ago.

Aptos price analysis
On the daily chart, Aptos has broken out of a multi-month descending triangle pattern, characterized by a flat lower trendline acting as support and a descending upper trendline forming resistance. A breakout from this pattern leads to a bullish reversal, as momentum shifts in favor of bulls.

Aptos price has confirmed a bullish reversal on the daily chart — Oct. 3 | Source: crypto.news
Aptos price moved above the upper trendline today and successfully retested it as support, which further cemented the bullish outlook among traders.

The Supertrend indicator has also flashed a green signal as it moved below the price level. On top of that, the MACD line has crossed above the signal line, with both trending upward.

Based on these positive technical signals, the next target for APT lies at $8.20, derived by adding the height of the triangle formed to the price point at which the breakout occurred. This target remains 56% above the current price levels.

A drop below $5 would invalidate the setup and could trigger renewed pressure from bears, exposing the token to further downside.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.